Yield10 Bioscience Inc reports results for the quarter ended in December - Earnings Summary

Yield10 Bioscience

14/03/2023 21:02

* Yield10 Bioscience Inc  YTEN.OQ  reported a quarterly
adjusted
loss of 67 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 60 cents per share.
    * Revenue fell 42.8% to $87.00 thousand from a year ago;
analysts
expected $125.00 thousand. 
    * Yield10 Bioscience Inc's reported EPS for the quarter was
a loss
of 67 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Yield10 Bioscience Inc shares had risen by 55.7% this
quarter.
    * The company reported a quarterly loss of $3.3 million.
    * Wall Street's median 12-month price target for Yield10
Bioscience Inc is $12.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 14 at 09:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.60          -0.67          Missed
 Sep. 30 2022      -0.65          -0.71          Missed
 Jun. 30 2022      -0.69          -0.70          Missed
 Mar. 31 2022      -0.65          -0.68          Missed